Company intelligence / Profile preview

Anagenex

Lexington, Massachusetts, United Statesanagenex.com ↗

Ownership: Private
Employees: ~29
Development stage: Other

Overview

Anagenex is developing an AI-driven drug discovery platform that tests billions of custom-synthesized compounds and uses proprietary neural networks to design new compounds. The company can synthesize and test 100 million compounds in just one month, with over 100 billion datapoints collected to accelerate drug discovery

Modalities: Small molecules
Industry: Drug Discovery Services

Beyond the preview

Go deeper on Anagenex.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Anagenex.

Explore the full profile